SOT & ToxExpo 2019 Exhibitor Hosted Session
Citoxlab & emka TECHNOLOGIES
Recent Advances in ECG Analysis for ProArrhythmia Risk Assessment: The Need to Read Between the Lines
In the last 5 years, FDA has actively characterized innovative ECG analysis methods for proarrhythmia assessments in clinical trials. ECG is a cornerstone of cardiac safety monitoring in toxicology and safety pharmacology with similarities between clinical and non-clinical evaluations. The session will compare well established ECG analysis methods used in toxicology with novel strategies that may offer lower false positive rates. Critical success factors in the analysis of pre-clinical ECGs will also be discussed.
WHEN: March 12, 2018 / 12:00 - 13:00
WHERE: SOT & ToxExpo 2019, Baltimore Convention Center / Meeting Room 337
SPEAKER: Simon Authier, DVM, MBA, PhD, DSP - Deputy Chief Scientific Officer, Citoxlab North America
Please fill in the form below to register for this event. We are looking forward to seeing you in Baltimore!
Your emka TECHNOLOGIES Team